FHTX
Foghorn Therapeutics Inc.
+0.11 (+2.64%)4.28USD83.6K成交股數254M市值–本益比(近四季)6.9股價營收比+112.7%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 16.1M+170% | 3.3M+14% | 8.2M+4% | 7.6M+10% | 6.0M+18% | 2.9M-84% | 7.8M+39% | 6.9M+30% | 5.1M | 17.5M | 5.6M | 5.3M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 18.5M | 18.3M | 20.0M | 21.8M | 21.6M | 20.5M | 24.7M | 23.8M | 25.5M | 26.3M | 29.2M | 30.0M |
| 銷售管理費用 | 6.4M | 6.6M | 6.7M | 6.9M | 7.2M | 6.4M | 7.0M | 7.3M | 7.7M | 8.3M | 8.4M | 8.6M |
| 營業利益 | −8.8M-62% | −21.6M-10% | −18.5M-22% | −21.1M-21% | −22.9M-19% | −24.0M+41% | −23.9M-26% | −26.6M-20% | −28.2M | −17.1M | −32.1M | −33.3M |
| 營業利益率 | -54.8% | -660.3% | -226.9% | -279.2% | -385.0% | -840.5% | -305.5% | -386.6% | -558.3% | -97.7% | -572.4% | -627.6% |
| 稅後淨利 | −7.2M-62% | −19.9M+2% | −15.8M-17% | −17.9M-22% | −18.8M-25% | −19.5M+36% | −19.1M-35% | −23.0M-25% | −25.0M | −14.3M | −29.5M | −30.5M |
| 淨利率 | -44.7% | -608.4% | -194.4% | -237.3% | -316.4% | -682.9% | -244.9% | -333.6% | -495.4% | -82.1% | -526.6% | -574.3% |
| 稀釋 EPS | -0.10-67% | -0.29+26% | -0.25-19% | -0.28-38% | -0.30-49% | -0.23-32% | -0.31-56% | -0.45-38% | -0.59 | -0.34 | -0.70 | -0.73 |
| 稀釋股數 | 70.6M | 69.5M | 63.0M | 63.0M | 62.8M | 54.9M | 62.6M | 51.6M | 42.4M | 42.0M | 41.8M | 41.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 68.1M | 87.7M | 89.3M | 72.6M | 61.0M | 55.5M | 57.7M | 139M | 79.3M | 70.3M | 57.7M | 50.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 203M | 222M | 205M | 226M | 259M | 284M | 308M | 329M | 255M | 313M | 340M | 373M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 284M | 299M | 295M | 303M | 320M | 330M | 337M | 343M | 352M | 371M | 389M | 397M |
| 股東權益 | −81.0M | −76.4M | −89.7M | −76.7M | −61.7M | −45.5M | −28.3M | −14.3M | −97.5M | −57.4M | −49.4M | −24.6M |
| 負債比 | 139.8% | 134.4% | 143.7% | 133.9% | 123.8% | 116.0% | 109.2% | 104.4% | 138.2% | 118.3% | 114.5% | 106.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −25.3M | – | – | −24.0M-18% | – | – | – | −29.3M | – | – | −31.2M |
| 資本支出 | – | 0.00 | – | – | 28K | – | – | – | 101K | – | – | 636K |
| 自由現金流 | – | −25.3M | – | – | −24.0M-19% | – | – | – | −29.4M | – | – | −31.8M |
| 折舊攤銷 | 200K | 238K | 900K | 900K | 827K | 785K | 700K | 800K | 835K | 900K | 800K | 859K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -773.4% | – | – | -403.2% | – | – | – | -583.1% | – | – | -599.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 30.9M
| The | 30.9M | 100.0% | +36.8% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 30.9M | +36.8% | −74.3M | -240.3% | -1.18 | −86.1M |
| FY2024 | 22.6M | -33.8% | −86.6M | -383.2% | -1.58 | −101M |
| FY2023 | 34.2M | +77.6% | −98.4M | -288.2% | -2.34 | −119M |
| FY2022 | 19.2M | +1357.8% | −109M | -566.3% | -2.62 | 192M |
| FY2021 | 1.3M | +206.7% | −101M | -7,681.6% | -2.73 | −53.6M |
| FY2020 | 430K | – | −68.8M | -16,000.0% | -6.23 | −47.5M |
| FY2019 | – | – | −51.1M | –% | -12.20 | −47.3M |